Brawn Biotech Announces 41st AGM on Sep 29, 2026
Brawn Biotech Ltd has issued a notice for its 41st Annual General Meeting (AGM) scheduled for September 29, 2026. The meeting will be conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM). The company will present the Audited Financial Statements for FY 2025-26, along with the Directors' and Auditors' reports. Key agenda items include the appointment of a director retiring by rotation and the appointment of statutory auditors. Additionally, the AGM will consider and approve managerial remuneration for Mr. Amit Kumar, Manager (KMP), amounting to ₹9,76,512 per annum for three years. The notice also details the timelines for remote e-voting, with the cut-off date on September 22, 2026, and voting open from September 26 to September 28, 2026.
Key Highlights
- 41st AGM scheduled for September 29, 2026, via VC/OAVM.
- Annual Report 2025-26 and financial statements to be presented.
- Director re-appointment and statutory auditor appointment on agenda.
- Managerial remuneration for Amit Kumar to be approved.
- E-voting period: September 26-28, 2026.
Price Impact
More from BRAWN